Latest Breaking News On - Route of administration intravenous - Page 12 : vimarsana.com

US General Anesthesia Drugs Market worth $2.4 billion by 2025 - Exclusive Report by MarketsandMarkets US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025 , published by MarketsandMarkets, the US general anesthesia drugs market size is projected to reach USD 2.4 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 3.4% during the forecast period. Browse in-depth TOC on US General Anesthesia Drugs Market 39 - Tables Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=713 The rising prevalence of cancer, rapid growth in geriatric population, and increasing number of emergency surgeries are some of the major factors driving the growth of the US general anesthesia drugs.

United statesUnited kingdomKostenloser wertpapierhandelAashish mehraMode of purchase group purchasing organizationBaxter international incGilead sciences incRoute of administration intravenousMerck co incPiramal enterprises limited indiaPfizer incPharmaceuticals market research reports consultingTeva pharmaceuticals israelFresenius se coHeritage pharmaceuticals incResearch insight